Lee Jin-Young, Kwon Jae-Woo, Park Jung-Seob, Han Kyeol, Shin Woo-Jin, Lee Jeong-Gil, Lee Byung Hoon
Department of Orthopedic Surgery, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
Hip Pelvis. 2015 Dec;27(4):250-7. doi: 10.5371/hp.2015.27.4.250. Epub 2015 Dec 30.
To evaluate clinical results of extracorporeal shock wave therapy (ESWT) with radiographic staging on patients with avascular necrosis of femoral head (AVNFH).
We evaluated 24 patients diagnosed with AVNFH (32 hip joints) who were treated with ESWT from 1993 to 2012. Average follow-up period was 27 months, and the average age of patients was 47.8 years. The Association Research Circulation Osseous (ARCO) system was used to grade radiographic stage prior to treatment. For this study patients were divided into two groups based on their ARCO stage, group 1 (ARCO stages I and II) and group 2 (ARCO stage III). Comparative analyses were done between the two groups using the visual analogue scale (VAS) score and the Harris hip score (HHS) at pre-treatment and 3, 6, 12, and 24 months after treatment. Failure was defined when radiographic stage progressed or arthroplasty surgery was needed due to clinical exacerbation.
Both groups showed clinical improvements with VAS scoring at final follow-up (group 1: median 7 to 1.5, P<0.001; group 2: mean 7 to 4, P=0.056). Using HHS, group 1 showed a significant improvement (from 65.5 to 95 [P<0.001]), while no significance was observed for group 2 (P=0.280). At final follow-up, 3 hips from group 1 and one hip from group 2 showed radiographic improvement; however, two patients underwent total hip arthroplasty due to persistent pain and dysfunction.
ESWT can be considered as an interventional option before surgical treatment in patients with not only early stage AVNFH but also with mid stage.
评估体外冲击波疗法(ESWT)结合影像学分期对股骨头缺血性坏死(AVNFH)患者的临床疗效。
我们评估了1993年至2012年间接受ESWT治疗的24例诊断为AVNFH的患者(32个髋关节)。平均随访期为27个月,患者平均年龄为47.8岁。治疗前采用骨循环研究协会(ARCO)系统对影像学分期进行分级。在本研究中,根据ARCO分期将患者分为两组,第1组(ARCO I期和II期)和第2组(ARCO III期)。使用视觉模拟量表(VAS)评分和Harris髋关节评分(HHS)在治疗前以及治疗后3、6、12和24个月对两组进行比较分析。当影像学分期进展或因临床症状加重需要进行关节置换手术时定义为治疗失败。
两组在末次随访时VAS评分均显示临床改善(第1组:中位数从7降至1.5,P<0.001;第2组:平均数从7降至4,P=0.056)。使用HHS评分,第1组有显著改善(从65.5提高到95 [P<0.001]),而第2组未观察到显著差异(P=0.280)。在末次随访时,第1组有3个髋关节和第2组有1个髋关节显示影像学改善;然而,两名患者因持续疼痛和功能障碍接受了全髋关节置换术。
ESWT不仅可被视为早期AVNFH患者,也可作为中期患者手术治疗前的一种干预选择。